A collaborative team from Penn Medicine and Penn Engineering has uncovered the mathematical principles behind a 500-million-year-old protein network that determines whether foreign materials are recognized as friend or foe.
How does your body tell the difference between friendly visitors, like medications and medical devices, and harmful invaders such as viruses and other infectious agents? According to Jacob Brenner, a physician-scientist at the University of Pennsylvania, the answer lies in a protein network that dates back over 500 million years, long before humans and sea urchins evolved along separate paths.
"The complement system is perhaps the oldest-known part of our extracellular immune system," says Brenner. "It plays a crucial role in identifying foreign materials like microbes, medical devices, or new drugs—particularly the larger ones like in the COVID vaccine."
The complement system can act as both protector and aggressor, offering defense on one side while harming the body on the other. In some cases, this ancient network worsens conditions like stroke by mistakenly targeting the body's own tissues. As Brenner explains, when blood vessels leak, complement proteins can reach brain tissue, prompting the immune system to attack healthy cells and leading to worse outcomes for patients.
Now, through a combination of laboratory experiments, coupled differential equations, and computer-based modeling and simulations, an interdisciplinary team from the School of Engineering and Applied Science and the Perelman School of Medicine has uncovered the mathematical principles behind how the complement network "decides" to launch an attack.

In their study published in Cell, the team identifies a molecular tipping point known as the critical percolation threshold. This threshold depends on how closely complement-binding sites are spaced on the surface of the model invader they designed. If the sites are too far apart, complement activation fades. If they are close enough—below the threshold—it triggers a chain reaction, rapidly recruiting immune agents in a response that spreads like wildfire.
"This discovery enables us to design therapeutics the way you would design a car or a spaceship—using the principles of physics to guide how the immune system will respond—rather than relying on trial and error," says Brenner, who is co-senior author of the study.
Simplifying complexity
While many researchers try to break complex biological systems down into smaller parts such as cells, organelles, and molecules, the team took a different approach. They viewed the system through a mathematical lens, focusing on basic values like density, distance, and speed.
"Not every aspect of biology can be described that way," says co-senior author Ravi Radhakrishnan, bioengineering chair and professor in Penn Engineering. "The complement pathway is fairly ubiquitous across many species and has been preserved through a very long evolutionary time, so we wanted to describe the process using a theory that's universal."
First, a team from Penn Medicine, led by materials scientist Jacob Myerson and nanomedicine research associate Zhicheng Wang, precisely engineered liposomes—tiny, nanoscale fat particles often used as a drug-delivery platform—by studding them with immune-system binding sites. They generated dozens of liposome batches, each with a precisely tuned density of binding sites, and then observed how complement proteins bound and spread in vitro.
The team then analyzed the experimental data with mathematical tools to assess the binding spread dynamics and immune element recruitment rates and used computational tools to visualize and simulate the reactions to identify when thresholds were being approached.
What they observed in the lab—that closer spacing of proteins ramped up immune activity—became much clearer when viewed through a mathematical lens.
The team's approach drew from complexity science, a field that uses math and physics to study systems with many moving parts. By stripping away the biological specifics, they were able to identify fundamental patterns—like tipping points and phase changes—that explain how the immune system decides when to strike.
"We took that initial observation and then tried to control precisely how closely spaced proteins were on the surface," Myerson says. "We found that there's this threshold spacing that's really the key to understanding how this complement mechanism can turn on or off in response to surface structure."
"If you look only at the molecular details, it's easy to think that every system is unique," adds Radhakrishnan. "But when you model complement mathematically, you see a pattern emerge, not unlike how forest fires spread, or hot water percolates through coffee grounds."
The process of percolation
While much of the research on percolation took place in the 1950s, in the context of petroleum extraction, the physics matched those the researchers observed in complement proteins. "Our system's dynamics map entirely onto the equations of percolation," says Myerson.
Sahil Kulkarni, a doctoral student in Radhakrishnan's lab, not only found that the mathematics of percolation predicted the experimental results that Brenner and Myerson's teams observed, but that complement activation follows a discrete series of steps.
First, an "ignition event" occurs, in which a foreign particle makes contact with the immune system. "It's like an ember falling in a forest," says Kulkarni. "If the trees are spaced too far apart, the fire doesn't spread. But if they're close together, the whole forest burns."
Just like some trees in a forest fire only get singed, percolation theory in the context of biology predicts that not all foreign particles must be fully coated in complement proteins to trigger an immune response. "Some particles are fully engulfed, while others get just a few proteins," Kulkarni explains.
It might seem suboptimal, but that patchiness is likely a feature, not a bug—and one of the chief reasons that evolution selected percolation as the method for activating complement in the first place. It allows the immune system to respond efficiently by coating only "enough" foreign bodies for recognition without overexpending resources or indiscriminately attacking every particle.
Unlike ice formation, which spreads predictably and irreversibly from a single growing crystal, percolation allows for more varied, flexible responses, even ones that can even be reversed. "Because the particles aren't uniformly coated, the immune system can walk it back," adds Kulkarni.
It's also energy efficient. "Producing complement proteins is expensive," says Radhakrishnan. "Percolation ensures you use only what you need."
The next steps along the discovery cascade
Looking ahead, the team is excited to apply their mathematical framework to other complex biological networks such as the clotting cascade and antibody interactions, which rely on similar interactions and dynamics.
"We're particularly interested in applying these methods to the coagulation cascade and antibody interactions," says Brenner. "These systems, like complement, involve dense networks of proteins making split-second decisions, and we suspect they may follow similar mathematical rules."
Additionally, their findings hint at a blueprint for designing safer nanomedicines, Kulkarni notes, explaining how formulation scientists can use this to fine-tune nanoparticles—adjusting protein spacing to avoid triggering complement. This could help reduce immune reactions in lipid-based vaccines, mRNA therapies, and CAR T treatments, where complement activation poses ongoing challenges.
"These kinds of problems live at the intersection of fields," says Myerson. "You need science and engineering know-how to build precision systems, complexity science to reduce 100s of equations modeling each protein-protein interaction to an essential three, and medical professionals who can see the clinical relevance. Investing in team science accelerated these outcomes."
Reference: "A percolation phase transition controls complement protein coating of surfaces" by Zhicheng Wang, Sahil Kulkarni, Jia Nong, Marco Zamora, Alireza Ebrahimimojarad, Elizabeth Hood, Tea Shuvaeva, Michael Zaleski, Damodar Gullipalli, Emily Wolfe, Carolann Espy, Evguenia Arguiri, Jichuan Wu, Yufei Wang, Oscar A. Marcos-Contreras, Wenchao Song, Vladimir R. Muzykantov, Jinglin Fu, Ravi Radhakrishnan, Jacob W. Myerson and Jacob S. Brenner, 13 June 2025, Cell.
DOI: 10.1016/j.cell.2025.05.026
Additional support came from the Pennsylvania Department of Health Research Formula Fund (Award W911NF1910240), the Department of Defense (Grant W911NF2010107), and National Science Foundation (Grant 2215917). Funding was also provided by the Chancellor's Grant for Independent Student Research at Rutgers University–Camden. Instrumentation was supported in part by the Abramson Cancer Center (NCI P30 016520) and Penn Cytomics and Cell Sorting Shared Resource Laboratory (RRID: SCR_022376.)
News
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]















